Venus Aerospace
Venus Aerospace Raises $91M Series B for Rotating Detonation Rocket Engines
Venus Aerospace announced $91M in Series B financing on July 8, 2026. Venus Aerospace raised a $91 million Series B led by Mercury Fund to scale development and production of its rotating detonation rocket engine propulsion systems.
Round details
The financing includes backing from Mercury Fund, Lockheed Martin Ventures, MESH, PEAK6, Draper Associates, Starboard Star Venture Capital, Green Sands Equity. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $91M
- Headquarters: Houston, TX
How the company plans to use the capital
Venus said the round will fund the scaling of development and production of its rotating detonation rocket engine (RDRE) propulsion system, moving it from flight demonstration toward deployment in near-term defense and space applications.
Why this matters for GTM teams
The round was led by Mercury Fund, with participation from Lockheed Martin Ventures, MESH, PEAK6, Draper Associates, Starboard Star Venture Capital, Green Sands Equity and other new and existing strategic and institutional investors.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Venus Aerospace Series B announcement.
Company Info
Investors (7)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


